Treatment of fungal infections in immunocompromised patients;Tratamiento de las infecciones por hongos en pacientes inmunodeprimidos

Revista Iberoamericana de Micologia

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Ribacoba, Laureano ^a,b   Montejo, Miguel ^a   Aguirrebengoa, Koldo ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Immunocompromised host; Mycosis; Saprophytic; Treatment

Indexed keywords

EID: 6744275351     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Armstrong D History of opportunistic infections in the immunocompromised host Clin Infect Dis 1993, 17 S318-S321.
2. Dismukes WE Management of cryptococcosis Clin Infect Dis 1993, 17 S507-S512
3. Bennett JE, Dismukes WE, Duma RJ, et al A comparison of amphotericin B alone or combined with flucytosine in the treatment of cryptococcal meningitis N Engl J Med 1979 301 126-131
4. Saag MS, Powderly EG, Cloud GA, et al Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis N Engl J Med 1992, 326 83-89
5. Polsky B, Depman MR, Gold JWM, Galicich JH, Armstrong D, Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med 1986, 81 24-28
6. Bozzette SA, Larsen RA, Chiu J, et al A paceblo-controled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324 580-4
7. Powderly WG, Saag MS, Cloud GA, et al A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome N Engl J Med 1992 326 793-8
8. Ribacoba L Aguirre JM, Quindós G, Aguirrebengoa K, Montejo M, Alvarez-Blanco A Identificación y caracterización de Candida en pacientes VIH (+) en Vizcaya En programa oficial del Il Congreso Europeo de Medicina Oral Granada, España 8-10 de Septiembre de 1994 Granada Ed Fondo Sanitario Médico y Universitario
9. Pons V, Greenspan D, Debruin M, et al Therapy for oropharyngeal candiasis in HIV-infected patients a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches J Aids 1993 6:1311-16.
10. Chave JP, Cajot A, Bille J Glauser MP Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults a pilot study J Infect Dis 1989, 159:806-7
11. 9 fluconazole in the treatment and prophylaxis or oral candidosis in HIN-infected patients J Drug Dev 1993, 5 235-9
12. Laine L, Dretler RH, Conteas CN, et al Fluconazole compared with ketoconazole for the treatment of Candida esophagttis in AIDS Ann Intern Med 1992 117 655-60
13. Heinic GS, Stevens DA Fluconazole-resistant Candida in AIDS patients Report of two cases Oral Surg Oral Med Oral Pathol 1993 76 711-5
14. Boken FDJ, Swindells S Rinaldi MG Fluconazole-resistant Candida albicans Clin Infect Dis 1993, 17:1018-21
15. Baily GG, Perry FM, Denning DW, Mandal BK. Fluconazole-resistant candidosis in an HIV cohort AIDS 1994, 8 787-02.
16. Just-Nubling G, Gentschew G, Meiâner K, et al Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive parents Eur J Clin Microbiol Infect Dis 1991; 10 917-21
17. Leen CLS, Dunbar EM, Ellis ME, Mandal BK Fluconazol una vez a la semana para prevenir recurrencia de candidiasis orofaringea en pacientes con SIDA y complejo relacionado con el SIDA Estudio doble-ciego controlado con placebo J Infect Dis 1990, 21, 55-60
18. Redding S, Smith J Fannacci G, et al Resistance of Candida albicans to fluconazole during treatment of orapharyngeal candidiasis in a patient with AIDS documentation by in vitro susceptibility testint and DNA subtype analysis Clin Infect Dis 1994, 18:240-2
19. Lecciones JA, Lee JW, Navarro EE, et al Vesicular catheter-associated fungemia in patients with cancer analysis of 155 episodes. Clin Infect Dis 1992, 14 875-883
20. Swerdloff JN, Filler SG, Edwards JE Severe candidal infections in neutropenic patients Clin Infect Dis 1993, 17: S457-S467
21. von't Wout JW. Itraconazole in neutropenic patients. Chemotherapy 1992, 38: S23-S26
22. Filler SG, Crilip MA, Mayer CL, Edwards JE. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits Antimicrob Agents Chemother 1991; 35 288-82
23. Bodey GP, Samonis G, Rolston K, Prophylaxis of candidiasis in cancer patients Semin Oncol 1990, 17 S24-28
24. Goodman JL, Winston DJ, Greenfiels RA, et al A controled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 1992, 845-51
25. Palmblad J, Lönnqvist B, Carlsson B, et al Oral ketoconazole prophylaxis for candida infections dunng induction therapy for acute leukaemia in adults more bacteraemias J Intern Med 1992, 231:363-370.
26. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325 1274-7
27. Andriole TV. Infections with Aspergillus species. Clin Infect Dis 1993, 17 S481-S486
28. Dening DW, Stevens DA Antifungal and surgical treatment of invasive aspegillosis, review of 2121 published cases Rev Infect Dis 1990, 12 1147-1201
29. Sugata T, Myoken Y, Kyo T, Fujihara M Invasive Oral aspergillosis in immunocompromised patients with leukemia J Oral Maxillofac Surg 1994; 52 382-86.
30. Carpentier JP, Ramamurthy L, Denning DW, Path MR, Taylor PH. An algorithmic approach to aspergillus sinusitis J Laryngol Otol 1994, 108:314-318
31. Dening DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole Am J Med 1989, 86 791-800
32. Rousey SR, Russler S Gottlieb M, Ash RC Low-dose amphotericin B prophylaxis against invasive Aspergillus infection in allogeneic marrow transplantation Am J Med 1991; 91:484-92.
33. Meunier F New methods for delivery of antifungal agents Rev Infect Dis 1989, 11 S1605-12
34. Vartivarian SE, Anaissie EJ, Bodey GP Emerging fungal pathogens in immunocompromised patients classification, diagnosis and management Clin Infect Dis 1993, 17 S487-91
35. Anaissie EJ, Bodey GP, Kantarjian H, et al New spectrum of fungal infections in patients with cancer Rev Infect Dis 1989, 11:369-378.
36. Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R Colonización and Infection with Trichosporon species in the immunosuppressed host J Infect Dis 1983; 147 189-202
37. Anaissie EJ, Gokaslan A, Hachem R, et al Azole theraphy for trichosporonosis clinical evaluation of eight patients, experimetal therapy for murine infection, and review. Clin Infect Dis 1992; 15 781-7.
38. Wals TJ, Lee JW, Melcher GP et al. Experimental Trichosporon infection in persistenly granulocytopenic rabbits' implications for pathogenesis, diagnosis and treatment of an emerging opportunistic mycosis J Infect Dis 1992; 166 121-33
39. Morrison VA, Weisdorf DJ Alternaria a sinonasal pathogen of immunocompromised host Clin Infect Dis 1993, 16:265-70
40. Matsuda T, Matsumoto T Disseminated hyalohyphomycosis in a leukemie patient Arch dermatol 1986, 122 1171-5
41. Weitzman I Saprophytic mold as agents of cutaneous and subcutaneous infection in the immunocompromised host Arch Dermatol 1986, 122 1161-85
42. Cohen-Abbo A Bozemen PM, Patrick CC Cuninghamella infections Review and report of two cases of Cunninghamella pneumonia in immunocompromised children Clin Infect dis 1993 17:173-7